chenodeoxycholic acid has been researched along with Alcoholic Liver Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, R; Liu, C; Ma, LJ; Su, H; Wan, JB; Wang, M; Yang, R; Yang, Y | 1 |
| Acco, A; Bastos-Pereira, AL; Chicorski, R; de Oliveira, LG; de Souza, CE; Dreifuss, AA; Fabossi, IA; Gremski, LH; Henneberg, R; Lívero, FA; Oude Elferink, RP; Rabitto, IS; Stolf, AM; Telles, JE | 1 |
2 other study(ies) available for chenodeoxycholic acid and Alcoholic Liver Diseases
| Article | Year |
|---|---|
Oxidation of fish oil exacerbates alcoholic liver disease by enhancing intestinal dysbiosis in mice.
Topics: Animals; Anti-Bacterial Agents; Chenodeoxycholic Acid; Dysbiosis; Ethanol; Fish Oils; Gastrointestinal Microbiome; Inflammation; Intestines; Liver; Liver Diseases, Alcoholic; Mice; Oxidation-Reduction; RNA, Ribosomal, 16S | 2020 |
The FXR agonist 6ECDCA reduces hepatic steatosis and oxidative stress induced by ethanol and low-protein diet in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Catalase; Chenodeoxycholic Acid; Cholesterol; Ethanol; Fatty Liver; Gastrointestinal Agents; Glutathione Transferase; Histocytochemistry; Liver Diseases, Alcoholic; Male; Mice; Oxidative Stress; Receptors, Cytoplasmic and Nuclear; Superoxide Dismutase; Triglycerides | 2014 |